Torthaí cuardaigh - Philip Petteruti
- 1 - 5 toradh as 5 á dtaispeáint
-
1
MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis <i>In Vivo</i> de réir David W. Jenkins, Sarah J. Ross, Margaret H. Veldman-Jones, Ian N. Foltz, Brandon C. Clavette, Kathy Manchulenko, Cath Eberlein, Jane Kendrew, Philip Petteruti, Song Cho, Melissa Damschroder, Li Peng, Dawn Baker, Neil R. Smith, Hazel M. Weir, David C. Blakey, Vahe Bedian, Simon T. Barry
Foilsithe / Cruthaithe 2012Artigo -
2
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer de réir Zebin Wang, Shaun Grosskurth, Tony Cheung, Philip Petteruti, Jingwen Zhang, Xin Wang, Wenxian Wang, Farzin Gharahdaghi, Jiaquan Wu, Nancy Su, Ryan T. Howard, Michele Mayo, Dan Widzowski, David A. Scott, Jeffrey W. Johannes, Michelle L. Lamb, Deborah Lawson, Jonathan R. Dry, Paul D. Lyne, Edward W. Tate, Michael Zinda, Keith Mikule, Stephen E. Fawell, Corinne Reimer, Huawei Chen
Foilsithe / Cruthaithe 2018Artigo -
3
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies de réir Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao, Austin Dulak, Wenxian Wang, Philip Petteruti, Ian L. Dale, Scott Boiko, Tony Cheung, Jingwen Zhang, Shenghua Wen, Lillian Castriotta, Deborah Lawson, Michael P. Collins, Larry Bao, Miika Ahdesmäki, Graeme E. Walker, Greg O’Connor, Tammie C. Yeh, Alfred A. Rabow, Jonathan R. Dry, Corinne Reimer, Paul D. Lyne, Gordon B. Mills, Stephen E. Fawell, Michael J. Waring, Michael Zinda, Edwin Clark, Huawei Chen
Foilsithe / Cruthaithe 2016Artigo -
4
Potent and selective bivalent inhibitors of BET bromodomains de réir Michael J. Waring, Huawei Chen, Alfred A. Rabow, Graeme E. Walker, Romel Bobby, Scott Boiko, Rob H. Bradbury, Rowena Callis, Edwin Clark, Ian L. Dale, Danette L. Daniels, Austin Dulak, Liz Flavell, Geoffrey A. Holdgate, Thomas A. Jowitt, Alexey Kikhney, M. McAlister, Jacqui Méndez, D. Ogg, Joe Patel, Philip Petteruti, Graeme R. Robb, Matthew B. Robers, Sakina Saif, Natalie Stratton, Dmitri I. Svergun, Wenxian Wang, David Whittaker, David M. Wilson, Yi Yao
Foilsithe / Cruthaithe 2016Artigo -
5
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6 de réir William McCoull, Tony Cheung, Erica Anderson, Peter Barton, Jonathan Burgess, Kate F. Byth, Qing Cao, M. Paola Castaldi, Huawei Chen, Elisabetta Chiarparin, Rodrigo J. Carbajo, Erin Code, Suzanna Cowan, Paul R. J. Davey, Andrew D. Ferguson, Shaun Fillery, Nathan O. Fuller, Ning Gao, David Hargreaves, Martin Howard, Jun Hu, Aarti Kawatkar, Paul D. Kemmitt, Elisabetta Leo, Daniel M. Molina, Nichole O’Connell, Philip Petteruti, Timothy Rasmusson, Piotr Raubo, Philip B. Rawlins, Piero Ricchiuto, Graeme R. Robb, Monica Schenone, Michael J. Waring, Michael Zinda, Stephen E. Fawell, David M. Wilson
Foilsithe / Cruthaithe 2018Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Cancer research
Chemistry
Biochemistry
Immunology
Antibody
BET inhibitor
BRD4
Bromodomain
Gene
Genetics
Histone
In vivo
Medicine
Angiogenesis
B cell
BCL6
Binding site
Biophysics
Biotechnology
Bivalent (engine)
Breast cancer
Cancer
Cell
Cell biology
Cell culture
Chromatin
Computational biology
Drug discovery
Endothelial stem cell